The peptidoglycan cell wall is essential for the survival and morphogenesis of bacteria 1 . For decades, it was thought that only class A penicillin-binding proteins (PBPs) and related enzymes effected peptidoglycan synthesis. Recently, it was shown that RodA-a member of the unrelated SEDS protein family-also acts as a peptidoglycan polymerase 2-4 . Not all bacteria require RodA for growth; however, its homologue, FtsW, is a core member of the divisome complex that appears to be universally essential for septal cell wall assembly 5,6 . FtsW was previously proposed to translocate the peptidoglycan precursor lipid II across the cytoplasmic membrane 7,8 . Here, we report that purified FtsW polymerizes lipid II into peptidoglycan, but show that its polymerase activity requires complex formation with its partner class B PBP. We further demonstrate that the polymerase activity of FtsW is required for its function in vivo. Thus, our findings establish FtsW as a peptidoglycan polymerase that works with its cognate class B PBP to produce septal peptidoglycan during cell division.
therapeutic targets. Phylogenetic analysis has shown that the SEDS proteins RodA and FtsW are more widely conserved than the aPBPs 2 . RodA, which serves as a key component of the Rod complex (elongasome) that makes side wall peptidoglycan, is absent or dispensable in some organisms 6, 9, 10 . In contrast, FtsW is required for the function of the division machinery (divisome) and is essential in most bacteria regardless of their shape 6, 9, 10 .
The Rod complex and divisome each contain an essential bPBP that forms a complex with its cognate SEDS protein within the machinery [11] [12] [13] [14] . Therefore, the recent discovery that RodA has peptidoglycan polymerase activity has led to the proposal that SEDS-bPBP complexes form two-component peptidoglycan synthases with polymerase and crosslinking activities on separate polypeptides (Fig. 1b) [2] [3] [4] . Accordingly, mutations predicted to disrupt RodA interactions with its cognate elongasome bPBP cause the Rod system to malfunction in vivo 11 . However, polymerase activity has thus far only been demonstrated for RodA from Bacillus subtilis 2, 11 . Whether FtsW, which shares key residues with RodA ( Supplementary Fig. 1 ), also functions as a peptidoglycan polymerase remains unclear.
To address this question, we first expressed and purified FtsW orthologues from the Gram-positive bacteria Streptococcus thermophilus (StFtsW) and Staphylococcus aureus (SaFtsW) in Escherichia coli ( Supplementary Fig. 2 ), but failed to detect polymerase activity (Fig. 1c ) when the proteins were incubated with their native lipid II substrate ( Fig. 1d and Supplementary Fig. 3 ) 15, 16 . Strikingly, when we added the cognate divisome bPBP to the FtsW reactions, peptidoglycan polymers were produced, implying that bPBP stimulates peptidoglycan polymerase activity ( Fig. 1d and Supplementary Fig. 3 ). The observed polymerase activity was abolished when an invariant aspartate in or near the presumed FtsW active site was mutated to alanine, but not when the transpeptidase active site of the bPBP was inactivated ( Fig. 1d and Supplementary  Figs. 1 and 3) . Furthermore, the activity of FtsW was insensitive to the phosphoglycolipid antibiotic moenomycin that inhibits aPBPs and MGTs ( Supplementary Fig. 4 ). Another distinction between FtsW and the other class of polymerases is that FtsW polymerase activity requires divalent cations. Ethylenediaminetetraacetic acid (EDTA) abolished StFtsW polymerase activity, but adding excess Mg 2+ , Ca 2+ or Mn 2+ to the EDTA-containing reactions restored polymerization ( Fig. 1e and Supplementary Fig. 5 ). Zn 2+ did not stimulate polymerase activity ( Supplementary Fig. 5 ). We conclude FtsW is a peptidoglycan polymerase that is functional only in complex with its cognate penicillin-binding protein 
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that FtsW is a peptidoglycan polymerase that requires divalent cations and the presence of a bPBP for activity.
Evolutionary sequence covariation analyses have demonstrated strong evolutionary couplings of residues within the transmembrane domain of bPBPs and transmembrane helices 8 and 9 of the SEDS proteins 11, 17 . This predicted interface is largely hydrophobic in character, suggesting that steric compatibility may determine interaction specificity ( Supplementary Fig. 6a ). We therefore wondered whether the transmembrane domain of a cognate bPBP is required for the PGT activity of FtsW. To address this question, we first removed the transmembrane (TM) domain from StPBP2x and tested the ability of the Δ TM variant (StPBP2x ∆TM ) to activate StFtsW. No peptidoglycan product was detected, suggesting that the transmembrane helix is crucial for promoting FtsW polymerase activity (Fig. 1d) . To assess the specificity of the polymerasepromoting activity of divisome bPBPs, we performed StFtsW and SaFtsW reactions in the presence of bPBPs from three different species ( Fig. 1f and Supplementary Fig. 7) . SaFtsW was only able to polymerize lipid II when combined with its native bPBP, S. aureus PBP1 (SaPBP1), but StFtsW was able to polymerize lipid II when combined either with its cognate bPBP, StPBP2x, or with the divisome bPBP from S. pneumoniae (SpPBP2x), which is 50% identical to its S. thermophilus counterpart and has a similar transmembrane helix ( Supplementary Fig. 6b ). StFtsW showed no activity in the presence of SaPBP1. We also swapped the transmembrane helices of the elongasome bPBP (PBP2b) and divisome bPBP (PBP2x) from S. thermophilus and S. pneumoniae ( Supplementary Fig. 2 ) and tested whether the resulting chimeras activate StFtsW polymerase activity. We found that StFtsW was activated only by chimeras containing a divisome bPBP transmembrane helix ( Supplementary Fig. 8 ). Finally, as steric complementarity is predicted to play an important role in SEDS-bPBP interactions, we made an S37F substitution in the transmembrane helix of StPBP2x that was expected to destabilize the interaction ( Supplementary Fig. 6c ). The polymerase activity of StFtsW was reduced, but could be restored by a compensatory L345G substitution at the complementary position in StFtsW ( Supplementary Fig. 6c,d) . These results, along with the evolutionary covariation analysis, imply that the transmembrane helix of the cognate bPBP interacts with FtsW and is necessary for the effect of this bPBP on FtsW polymerase activity. 
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To determine whether FtsW from a Gram-negative organism could form an active peptidoglycan synthase complex with its cognate bPBP, we co-expressed Pseudomonas aeruginosa FtsW (PaFtsW) with its divisome bPBP (PaPBP3) in E. coli. PaPBP3 copurified with the affinity-tagged FtsW, and the complex possessed polymerase activity ( Fig. 2a and Supplementary Fig. 9 ). We found that SaFtsW could also be co-expressed and purified as a stable, active complex with transpeptidase-inactive SaPBP1* ( Fig. 2b and Supplementary Fig. 9 ). Substitution of the invariant aspartate in or near the presumed active site of FtsW compromised the polymerase activity of both complexes ( Fig. 2a,2b and Supplementary  Fig. 1 ). To assess the in vivo relevance of the FtsW polymerase activity, we compared the effect of overproducing either wild-type FtsW or inactive FtsW variants (designated FtsW*) in P. aeruginosa and S. aureus. Cell growth and division remained normal on expression of wild-type FtsW (Fig. 2c,2d , Supplementary Figs. 10 and 11 and Supplementary Tables 1 and 2). However, production of PaFtsW* and SaFtsW* inhibited growth of P. aeruginosa and S. aureus, respectively ( Supplementary Fig. 10 ). Moreover, PaFtsW* induced cell filamentation in P. aeruginosa, and SaFtsW* caused septal abnormalities in S. aureus (Figs. 2c,2d, Supplementary Fig. 11 and Supplementary Tables 1 and 2 ). The observed dominant-negative activity of the FtsW* proteins in their host organism probably results from the defective proteins saturating FtsW binding sites in the divisome complex to disrupt the function of the machinery.
To further investigate the essentiality of FtsW polymerase activity, an FtsW depletion strain of S. pneumoniae was constructed. Expression of SpFtsW or StFtsW from a second locus rescued growth on SpFtsW depletion ( Fig. 2e and Supplementary Fig. 12 ). However, neither the corresponding FtsW* nor SaFtsW prevented the lethal SpFtsW depletion phenotype ( Fig. 2e and Supplementary  Fig. 12 ). Taken together, the genetic and biochemical results indicate that stable FtsW-bPBP complexes are formed in diverse bacteria and possess peptidoglycan polymerase activity that is required for growth and division.
Having shown that an appropriate bPBP is required for FtsW polymerase activity, we wondered whether FtsW has a reciprocal stimulatory effect on bPBP activity. To address this question, we used a liquid chromatography-mass spectrometry (LC-MS)-based assay to detect peptidoglycan crosslinks 16, 18 . Peptidoglycan synthesized in vitro was digested with mutanolysin ( Fig. 3a) . These digestions typically produce three readily detectable muropeptide species: pentapeptide starting material (monomer A), tetrapeptides resulting from hydrolysis of the terminal d-alanine of the pentapeptide (monomer B) and crosslinked units resulting from transpeptidase activity (dimer C) ( Fig. 3a ). When StPBP2x was incubated with StFtsW and lipid II, we observed an LC-MS peak in the mutanolysin digestions corresponding to the dimeric product ( Fig. 3b and Supplementary Fig. 13 ). Catalytic inactivation of StPBP2x led to the disappearance of this peak, confirming that it resulted from 
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the transpeptidase activity of this enzyme. The same dimeric species was observed when StPBP2x was combined with an MGT from S. aureus (SgtB) or with an aPBP with a defective transpeptidase active site, SpPBP1a*. We also observed crosslinked products when chimeric StPBPs or StPBP2x ∆TM were incubated with SgtB and lipid II ( Supplementary Fig. 14) . Because StPBP2x can crosslink peptidoglycan strands produced by other lipid II polymerases and does not require its transmembrane domain for crosslinking, we conclude that its activity is not dependent on its cognate FtsW partner.
Our studies have conclusively established that FtsW functions as a peptidoglycan polymerase. Although we cannot formally exclude the possibility that FtsW also has lipid II flippase activity, as previously proposed 7,8 , a growing body of evidence suggests that this function is largely, if not entirely, carried out by MurJ in vivo [19] [20] [21] . Unlike the aPBPs and related MGT enzymes, we discovered that the polymerase activity of FtsW requires divalent cations that prefer oxygen ligands as functional cofactors ( Supplementary Fig. 5 ) 22 . The most likely role of the cation is to anchor the diphosphate of the lipid II substrate and help neutralize its negative charge, but other functions are possible; structural information is needed to better understand the metal requirement. Similarly, structural information on the peptidoglycan synthase complex would illuminate how the bPBP associates with FtsW and promotes its polymerase activity. Many of the evolutionary couplings observed are between large side chains in one protein and small side chains in the other, and we have shown that disrupting one such interaction hinders polymerization activity ( Supplementary Fig. 6c,6d ). An attractive possibility is that these specific interactions between FtsW and bPBP promote the formation of an active conformation of FtsW in the complex. Although B. subtilis RodA had polymerase activity in the absence of its cognate bPBP 2 , the activity was weak and RodA may similarly be stimulated by complex formation.
Recent genetic and biochemical results also suggest that the polymerase activity of SEDS proteins requires an activation event beyond complexation with a bPBP partner in vivo 12 . Amino acid substitutions in the pedestal domain of PBP2 in E. coli were found to stimulate RodA activity in vivo and in vitro, and these PBP2 variants bypass the requirement for MreC and other components of the shape-determining system 12 . Similar changes in FtsW and PBP3 from E. coli and Caulobacter crescentus were found to overcome the action of division inhibitors and thus are thought to activate the divisome [23] [24] [25] . It therefore appears that the synthase activity of SEDS-bPBP complexes from both the Rod system and the divisome may be controlled by similar mechanisms within their respective machineries. The development of peptidoglycan polymerase assays for both FtsW and RodA now sets the stage for the molecular details of this regulation to be uncovered.
Another important outstanding question relates to the division of labour between FtsW-bPBP complexes and aPBPs during septal peptidoglycan biogenesis. In B. subtilis, cells remain viable in the absence of aPBPs, suggesting that the FtsW-bPBP complex plays a major, possibly sufficient, role in this process 26 . Septal peptidoglycan synthesis in B. subtilis is directly coupled to treadmilling of FtsZ, which colocalizes with PBP2b, the partner of FtsW 27 . However, most bacterial species require at least one aPBP for viability. In S. aureus, the essential aPBP, PBP2, is recruited to the septum and is thought to be crucial for cell division 28 . Contrasting with B. subtilis, the initial rate of septal peptidoglycan synthesis in S. aureus is slow and dependent on FtsZ treadmilling, but later in cytokinesis, peptidoglycan synthesis is independent of FtsZ treadmilling 29 . Thus, FtsW may serve as the major polymerase during treadmillingdependent cell division, with PBP2 largely responsible for the subsequent treadmilling-independent phase of peptidoglycan synthesis. Irrespective of their relative roles, both FtsW-bPBP complexes and the aPBPs are clearly critical for proper assembly of peptidoglycan. Further studies of their activity and regulation will therefore pave the way for the discovery of molecules that inhibit their function for future antibiotic development.
Methods
Materials. Unless otherwise indicated, all chemicals and reagents were purchased from Sigma-Aldrich. Restriction enzymes were purchased from New England Biolabs. Oligonucleotide primers were purchased from Integrated DNA Technologies. Culture media were purchased from Becton Dickinson. S. thermophilus LMG18311 genomic DNA was purchased from the American Type Culture Collection (ATCC BAA-250D-5). Biotin-d-lysine (BDL) was prepared by de-protecting Fmoc-biotin-d-lysine (Bachem) 18 . S. aureus lipid II and Enterococcus faecalis lipid II were isolated from cells as described previously 15, 16 . S. aureus SgtB, SgtB Y181D , PBP4 and E. faecalis PBPX were expressed and purified as previously reported 16, 18, 30 .
Bacterial strains, plasmids, oligonucleotide primers and culture conditions. E. coli strains were grown with shaking at 37 °C in lysogeny broth or Terrific Broth (Teknova) or on agarized lysogeny broth plates. S. aureus strains were grown with shaking at 30 or 37 °C in Tryptic Soy Broth (TSB) or on agarized plates. P. aeruginosa strains were grown with shaking at 30 °C in lysogeny broth or M9 broth containing 0.2% casamino acids and 0.2% glucose, or on agarized lysogeny broth plates. S. pneumoniae strains were grown statically in Todd Hewitt Broth containing 0.5% yeast extract (THY) at 37 °C in an atmosphere containing 5% CO 2 . When growth on solid media was required, S. pneumoniae strains were grown on pre-poured Trypticase Soy Agar with 5% Sheep Blood (TSAII 5%SB) plates with a 5 ml overlay of 1% nutrient broth agar or TSA plates containing 5% defibrinated sheep blood with appropriate additives. The following concentrations of antibiotics were used: ampicillin, 50 µ g ml −1 ; carbenicillin, 50 µ g ml −1 ; chloramphenicol, 35 µ g ml −1 ; erythromycin, 0.2 µ g ml −1 (S. pneumoniae) or 5 µ g ml −1 (S. aureus); gentamicin, 30 µ g ml −1 ; kanamycin, 50 µ g ml −1 (E. coli) or 250 µ g ml −1 (S. pneumoniae); tetracycline, 0.2 µ g ml −1 . The bacterial strains, plasmids and oligonucleotide primers used in this study are summarized in Supplementary Tables 3-5 .
Plasmid construction for protein expression. StFtsW. The stu0486 (M1-R426) gene encoding FtsW was amplified from S. thermophilus LMG18311 genomic DNA using primers oAT01 and oAT02. After digestion with NdeI and HindIII, 13 14 15 
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the PCR product was ligated into pET28b. The resulting plasmid pATPL107 expresses His 6 -StFtsW. Plasmid pATPL121, expressing His 6 -StFtsW D292A (catalytically inactive mutant StFtsW*), was PCR generated from pATPL107 with primers oAT03 and oAT04 containing the desired mutation. Plasmid pATPL185, expressing His 6 -StFtsW L345G , was generated from pATPL107 with primers oAT05 and oAT06 via In-Fusion Cloning (Takara Bio).
StPBP2x. The stu1701 (M1-D755) gene encoding PBP2x was amplified from S. thermophilus LMG18311 genomic DNA using primers oAT07 and oAT08. After digestion with NdeI and HindIII, the PCR product was ligated into pET22b. The resulting plasmid pATPL091 expresses StPBP2x-His 6 . Plasmid pATPL123, expressing StPBP2x G53-D755 -His 6 (StPBP2x ∆TM ), was constructed similarly using primers oAT09 and oAT08. The Phobius web server was used for the prediction of the transmembrane region 31 . Plasmid pATPL112, expressing StPBP2x S343A -His 6 (transpeptidase mutant StPBP2x*), was generated from pATPL091 with primers oAT10 and oAT11 via In-Fusion Cloning. Plasmid pATPL180, expressing StPBP2x S37F -His 6 , was generated from pATPL091 with primers oAT12 and oAT13 containing the desired mutation.
StPBP2b. The stu0613 (M1-H704) gene encoding PBP2b was amplified from S. thermophilus LMG18311 genomic DNA using primers oAT14 and oAT15. After digestion with NdeI and HindIII, the PCR product was ligated into pET22b. The resulting plasmid pATPL169 expresses StPBP2b-His 6 .
StPBP2b TM 2x ∆TM . The stu0613 (M1-M58) gene encoding the transmembrane domain of PBP2b and the stu1701 (G53-D755) gene encoding the extracellular domain of PBP2x were each amplified from S. thermophilus LMG18311 genomic DNA using the primer pairs oAT14/oAT16 and oAT17/oAT06. The two fragments were combined by overlap extension PCR. The resulting PCR product was digested with NdeI and HindIII before it was ligated into pET22b. The resulting plasmid pATPL172 expresses StPBP2b M1-M58 StPBP2x G53-D755 -His 6 .
StPBP2x TM 2b ∆TM . The stu1701 (M1-I52) gene encoding the transmembrane domain of PBP2x and the stu0613 (Q59-H704) gene encoding the extracellular domain of PBP2b were each amplified from S. thermophilus LMG18311 genomic DNA using the primer pairs oAT05/oAT18 and oAT19/oAT15. The two fragments were combined by overlap extension PCR. The resulting PCR product was digested with NdeI and HindIII before it was ligated into pET22b. The resulting plasmid pATPL173 expresses StPBP2x M1-I52 StPBP2b Q59-H704 -His 6 .
SaFtsW. The SAOUHSC_01063 (K2-N408) gene encoding FtsW was amplified from S. aureus NCTC 8325 genomic DNA using the primers oAT20 and oAT21. After digestion with NheI and NotI, the PCR product was ligated into pET28b. The resulting plasmid pMW2179 expresses His 6 -SaFtsW. Plasmid pMW2193, expressing His 6 -SaFtsW D287A (catalytically inactive mutant SaFtsW*), was PCR generated from pMW2179 with primers oAT22 and oAT23 containing the desired mutation.
SaPBP1. The SAOUHSC_01145 (A2-D744) gene encoding PBP1 was amplified from S. aureus NCTC 8325 genomic DNA using the primers oAT24 and oAT25. The PCR product was ligated into NcoI and NotI-cut pET28b via In-Fusion Cloning to produce plasmid pMW2194, which expresses SaPBP1-His 6 . Plasmid pMW2180, expressing SaPBP1 S314A -His 6 (transpeptidase mutant SaPBP1*), was PCR generated from pMW2194 with primers oAT26 and oAT27 containing the desired mutation.
SpPBP2x. The SPD_0306 (M1-D750) gene encoding PBP2x was amplified from S. pneumoniae D39 ∆ cps genomic DNA using the primers oAT28 and oAT29. After digestion with NdeI and HindIII, the PCR product was ligated into pET22b. The resulting plasmid pATPL017 expresses SpPBP2x-His 6 . Plasmid pATPL067, expressing SpPBP2x S337A -His 6 (transpeptidase mutant SpPBP2x*), was PCR generated from pATPL017 with primers oAT30 and oAT31 containing the desired mutation.
SpPBP2b. The SPD_1486 (M6-N685) gene encoding PBP2b was amplified from S. pneumoniae D39 ∆ cps genomic DNA using primers oAT32 and oAT33. After digestion with NdeI and HindIII, the PCR product was ligated into pET22b. The resulting plasmid pATPL084 expresses SpPBP2b-His 6 .
SpPBP2b TM 2x ∆TM . The SPD_1486 (M6-Y38) gene encoding the transmembrane domain of PBP2b and the SPD_0306 (T50-D750) gene encoding the extracellular domain of PBP2x were each amplified from S. pneumoniae D39 ∆ cps genomic DNA using the primer pairs oAT28/oAT34 and oAT35/oAT29. The two fragments were combined by overlap extension PCR. The resulting PCR product was digested with NdeI and HindIII before it was ligated into pET22b. The resulting plasmid pATPL170 expresses SpPBP2b M6-Y38 SpPBP2x T50-D750 -His 6 .
SpPBP2x TM 2b ∆TM . The SPD_0306 (M1-G49) gene encoding the transmembrane domain of PBP2x and the SPD_1486 (M39-N685) gene encoding the extracellular domain of PBP2b were each amplified from S. pneumoniae D39 ∆ cps genomic DNA using the primer pairs oAT28/oAT36 and oAT37/oAT29. The two fragments were combined by overlap extension PCR. The resulting PCR product was digested with NdeI and HindIII before it was ligated into pET22b. The resulting plasmid pATPL171 expresses SpPBP2x M1-G49 SpPBP2b M39-N685 -His 6 .
SpPBP1a. The SPD_0336 (M1-P719) gene encoding PBP1a was amplified from S. pneumoniae D39 ∆ cps genomic DNA using the primers oAT38 and oAT39. After digestion with NdeI and XhoI, the PCR product was ligated into pET22b. The resulting plasmid pATPL044 expresses SpPBP1a-His 6 . Plasmid pATPL051, expressing SpPBP1a S370A -His 6 (transpeptidase mutant SpPBP1a*), was PCR generated from pATPL044 with primers oAT40 and oAT41 containing the desired mutation.
PaFtsW-PBP3 co-expression. The PA4413 (M1-R399) and PA4418 (M1-G579) genes encoding FtsW and PBP3 were each amplified from P. aeruginosa PAO1 genomic DNA using the primer pairs oAT42/oAT43 and oAT44/oAT45, respectively. Plasmid pETDuet-FLAG, containing a His 6 -SUMO-FLAG tag at the first site and a His 6 at the second site, was amplified using primers oAT46 and oAT47. This plasmid also encodes a 3C protease site downstream of the FLAG tag, which is followed by a GGSS linker. Next, the intergenic region between the end of the first site and beginning of the second site, which contains the T7 promoter and an RBS for the second site, was amplified using primers oAT48 and oAT49. The PCR fragments for PA4413, the intergenic region and PA4418 were assembled and amplified by overlap extension PCR. This insert and the amplified vector backbone were assembled via isothermal assembly. The resulting plasmid pLSM3 expresses His-SUMO-FLAG-PaFtsW and PaPBP3-His 6 . Plasmid pLSM6, expressing His-SUMO-FLAG-PaFtsW D275A (catalytically inactive mutant PaFtsW*) and PaPBP3-His 6 , was generated from pLSM3 using single-oligonucleotide site directed mutagenesis with primer oAT50 containing the desired mutation.
SaFtsW-PBP1 co-expression. The SAOUHSC_01063 (K2-N408) gene encoding FtsW and the SAOUHSC_01145 (A2-D744) gene encoding PBP1 were amplified from S. aureus NCTC 8325 genomic DNA using the primers oAT51/oAT52 and oAT53/oAT54, respectively. Plasmid pETDuet-FLAG was amplified using primers oAT55 and oAT56 and the DNA fragment ligated with the FtsW insert via isothermal assembly. The resulting plasmid was amplified using primers oAT57 and oAT58, and the DNA fragment was ligated with the PBP1 insert via isothermal assembly. The resulting plasmid, pMW2127, expresses His-SUMO-FLAG-SaFtsW and SaPBP1-His 6 . Plasmid pMW2144, expressing His-SUMO-FLAG-SaFtsW and SaPBP1 S314A -His 6 (SaPBP1*), was PCR generated from pMW2127 with primers oAT26 and oAT27. Plasmid pMW2176, expressing His-SUMO-FLAG-SaFtsW D287A (SaFtsW*) and SaPBP1 S314A -His 6 (SaPBP1*), was PCR generated from pMW2144 with primers oAT22 and oAT23.
Protein expression: general procedure. For expression of Staphylococcus
and Streptococcus FtsW and PBPs, E. coli C43(DE3) containing the expression plasmid was grown in 1 l Terrific Broth supplemented with kanamycin or carbenicillin at 37 °C with shaking until absorbance A 600 nm was 0.7-0.8. The culture was cooled to 20 °C before inducing protein expression with 500 µ M isopropyl β -d-1-thiogalactopyranoside (IPTG). Cells were harvested 18 h post-induction by centrifugation (4,200g; 15 min; 4 °C), and the pellet was stored at − 80 °C.
Purification of Staphylococcus and Streptococcus FtsW: general protocol.
For the purification of FtsW, cells were resuspended in 50 ml lysis buffer A (50 mM HEPES pH 7.5 and 0.5 M NaCl) supplemented with 1 tablet of cOmplete EDTA-free Protease Inhibitor Cocktail. Cells were lysed by passaging the resuspended cells through a cell disruptor (EmulsiFlex-C3; Avestin) at 15,000 psi three times. Cell debris were removed by centrifugation (12,000g; 5 min; 4 °C), and the membrane fraction was collected by ultracentrifugation of the supernatant (100,000g; 1 h; 4 °C). The membrane pellet was resuspended in solubilization buffer A (50 mM HEPES pH 7.5, 0.5 M NaCl, 1% n-dodecyl β -d-maltoside (DDM) and 20% glycerol) using a glass Dounce tissue grinder (Wheaton). The resulting mixture was stirred for 1 h at 4 °C before ultracentrifugation (100,000g; 1 h; 4 °C). The resulting supernatant was supplemented with 0.5 ml pre-equilibrated Ni-NTA resin (Qiagen) and 20 mM imidazole, and stirred for 30 min at 4 °C. The sample was then loaded onto a gravity column and washed with 25 ml wash buffer A (50 mM HEPES pH 7.5, 0.5 M NaCl, 0.05% DDM and 20% glycerol) containing 20 mM imidazole, and 25 ml wash buffer A containing 40 mM imidazole. The protein was then eluted in 10 ml wash buffer A containing 300 mM imidazole. The eluate was further purified by size exclusion chromatography (SEC) with a Superdex 200 10/300 GL column (GE Healthcare) equilibrated in running buffer A (50 mM HEPES pH 7.5, 0.5 M NaCl, 10% glycerol and 0.05% DDM). Fractions containing the target protein were concentrated by centrifugal filtration. The absorbance at 280 nm was measured using a NanoDrop One Microvolume UV-Vis Spectrophotometer (Thermo Fisher Scientific) and the predicted extinction coefficient (ProtParam) was used to calculate the concentration 32 . Protein samples were then aliquoted and stored at − 80 °C.
Purification of full-length Staphylococcus and Streptococcus PBPs: general protocol. PBPs were purified via the same protocol as FtsW, as shown above, with the following modifications. Cells were resuspended in 50 ml lysis buffer A supplemented with 1 mM phenylmethylsulfonyl fluoride. For the solubilization buffer A and wash buffer A, 10% glycerol was used instead of 20%. For SEC, a Superose 6 10/300 GL column (GE Healthcare) was used.
Expression and purification of StPBP2x ∆TM . For the expression and purification of StPBP2x ∆TM , E. coli BL21(DE3) containing the expression plasmid was grown in 1 l lysogeny broth supplemented with carbenicillin at 37 °C with shaking until A 600 nm = 0.6. The culture was cooled to 16 °C before inducing protein expression with 500 µ M IPTG. Cells were harvested 18 h post-induction by centrifugation (4,200g; 15 min; 4 °C) and resuspended in 25 ml lysis buffer A supplemented with 1 mM phenylmethylsulfonyl fluoride. Cell were lysed using a cell disruptor, and the supernatant was collected after ultracentrifugation (100,000g; 30 min; 4 °C).
A pre-equilibrated 0.5 ml Ni-NTA resin and 20 mM imidazole were added and the resulting mixture was stirred for 30 min at 4 °C. The sample was loaded onto the gravity column and washed with 25 ml lysis buffer A supplemented with 20 mM imidazole, followed by 25 ml lysis buffer A supplemented with 40 mM imidazole.
The protein was then eluted in 10 ml lysis buffer A containing 300 mM imidazole.
The eluate was further purified by SEC with a Superdex 200 10/300 GL column equilibrated in running buffer A, and the fractions containing the target protein were combined, concentrated and stored at − 80 °C.
Co-expression and purification of SaFtsW-PBP1. For the expression of the
SaFtsW-PBP1 complex, E. coli C43(DE3), containing pAM174 (encodes arabinoseinducible Ulp1 protease) and the expression plasmid, was grown in 1 l Terrific Broth supplemented with carbenicillin and chloramphenicol at 37 °C with shaking until A 600 nm was 0.7-0.8. The culture was cooled to 20 °C before inducing protein expression with 500 µ M IPTG and 0.1% arabinose. Cells were harvested 18 h post-induction by centrifugation (4,200g; 15 min; 4 °C). The FtsW-PBP1 complex was purified via the same protocol as SaFtsW, as shown above, with the following modifications. Lysis, solubilization and wash buffers for the purification of FLAG-FtsW and PBP1-His 6 contained 150 mM NaCl. For the solubilization buffer A and wash buffer A, 10% glycerol was used. After the second ultracentrifugation, the resolubilized protein was applied to 500 µ l washed α -FLAG G1 affinity resin (GenScript). The resin was washed with 25 ml wash buffer B (50 mM HEPES pH 7.5, 150 mM NaCl, 0.2% DDM and 10% glycerol) followed by 25 ml wash buffer A. The protein was eluted in 10 ml wash buffer A supplemented with 0.2 mg ml −1 FLAG peptide (GenScript). 
Co-expression and purification of P. aeruginosa
Detection of PGT activity via western blot.
The protocol for detecting lipid II/ peptidoglycan was adapted from previously published methods 11, 18, 33 .
StFtsW. Unless otherwise stated, proteins (StFtsW, 0.5 µ M; bPBPs, 1 µ M; SgtB and SpPBP1a, 0.5 µ M) were added to a 1× reaction buffer (50 mM HEPES pH 7.5, 30% dimethyl sulfoxide (DMSO) and 2.5 mM MgCl 2 ) containing BDL (2 mM) and E. faecalis lipid II (10 µ M) in a total volume of 10 µ l. The samples were incubated at room temperature for 5 min (SgtB and SpPBP1a) or 30 min (StFtsW). The reaction was heat-quenched at 95 °C for 3 min and cooled to room temperature before the addition of 1 µ l E. faecalis PBPX (100 µ M) to the reaction mixture to label lipid II/ peptidoglycan with BDL. After 30 min, 11 µ l 2× Laemmli sample buffer was added to quench the labelling reaction. The samples were loaded onto a 4-20% gradient polyacrylamide gel (Bio-Rad) and run at 180 V. After the products were transferred onto a PVDF membrane (Bio-Rad), the membrane was blocked with SuperBlock (TBS) Blocking Buffer (Thermo Fisher Scientific) for 30 min. For detection of biotin-labelled products, IRDye 800CW Streptavidin (LI-COR Biosciences) was added at a final concentration of 1:5,000 and the membrane was incubated for 1 h. The membrane was washed 3× for 10 min with Tris-buffered saline (TBS) and imaged using an Odyssey CLx imaging system (LI-COR Biosciences).
SaFtsW and FtsW-PBP1*. SaFtsW and bPBP stocks (50 µ M) were combined 1:1 and the mixture was chilled on ice for 30 min. The proteins (SaFtsW, 2.5 µ M; bPBPs, 2.5 µ M; SgtB, 1 µ M) were then added to a 1× reaction buffer (50 mM HEPES pH 7.5, 30% DMSO and 10 mM MgCl 2 ) containing BDL (3 mM), moenomycin (2 µ M) and S. aureus lipid II (10 µ M) in a total volume of 10 µ l. The samples were incubated at room temperature for 5 min (SgtB) or 1 h (SaFtsW). The reaction was heat-quenched at 95 °C for 10 min. After cooling, 0.5 µ l E. faecalis PBPX (200 µ M) was added to the reaction mixture and the samples were incubated for 45 min. Reactions were quenched by the addition of 10.5 µ l 2× Laemmli sample buffer. The protocol for the western blot was identical to the one used for StFtsW, as described above. Following the incubation, reactions were heat-quenched at 95 °C for 2 min. After cooling, 2 μ l BDL (20 mM) and 1 μ l S. aureus PBP4 (50 µ M) were added to the reaction mixture and the samples were incubated for 1 h. Reactions were quenched by the addition of 13 μ l of 2× Laemmli sample buffer and samples were loaded onto a 4-20% polyacrylamide gel. The peptidoglycan product was then transferred onto a PVDF membrane and the membrane was fixed by incubating in 0.4% paraformaldehyde in phosphate-buffered saline for 30 min. Subsequently, the blot was blocked using SuperBlock blocking buffer. The biotin-labelled products were detected by incubation with IRDye 800CW Streptavidin (1:5,000 dilution). The membrane was then washed 4 times with TBS with 0.05% Tween-20, followed by 1 wash with phosphate-buffered saline before imaging.
PaFtsW
LC-MS analysis of peptidoglycan crosslinking activity. This procedure was adapted from previous reports 16, 18 . E. faecalis lipid II (20 µ M), PGT (0.5 µ M) and bPBP (1 µ M) were incubated in a 30 µ l 1× reaction buffer (50 mM HEPES pH 7.5, 10 mM MgCl 2 and 30% DMSO) at 30 °C for 1 h unless otherwise indicated. The reactions were heat-quenched at 95 °C for 3 min and allowed to cool to room temperature. Polymerized material was digested by incubating the mixture at 37 °C for 3 h after the addition of 65 µ l double-distilled water and 5 µ l mutanolysin (from Streptomyces globisporus; 4,000 U ml −1 ). To reduce the muropeptide products, 50 µ l sodium borohydride (10 mg ml −1 ) was added and the mixture was incubated at room temperature for 30 min. The pH was adjusted to ~4 with 20% phosphoric acid and the samples were lyophilized to dryness overnight. The samples were resuspended in 20 µ l double-distilled water and analysed by LC-MS on an Agilent 6520 Q-TOF mass spectrometer with ESI-MS operating in positive mode. Muropeptide products were separated on a Waters Symmetry Shield RP18 column (5 µ m; 3.9 mm × 150 mm) with the following method: flow rate = 0.5 ml min −1 , 100% solvent A (H 2 O and 0.1% formic acid) for 5 min followed by a linear gradient of solvent B (acetonitrile and 0.1% formic acid) from 0-40% over 25 min. Molecular ions for the target muropeptide fragments were extracted from the total ion chromatogram.
S. aureus strain construction. The SAOUHSC_01063 (M1-N408) gene encoding FtsW was amplified from S. aureus RN4220 genomic DNA using primers oAT59 and oAT60. After digestion with SalI and BamHI, the PCR product was ligated into pLOW to produce pLOWftsW, which is an overexpression plasmid for SaftsW. To generate the D287A mutation, primer pairs oAT59/oAT62 and oAT61/ oAT60 containing the desired mutation were used to amplify SAOUHSC_01063 fragments. The two fragments were combined by overlap extension PCR, and the PCR product was ligated into pLOW, as described above. The resulting plasmid pLOWftsWD287A is an overexpression plasmid for SaftsW D287A . For transformation of S. aureus, plasmids were electroporated into wild-type RN4220 and the cells were recovered at 30 °C for 1-2 h. Cells were plated on TSB agar containing erythromycin, and the transformants were recovered after incubation for 1-2 d. P. aeruginosa strain construction. The PA4413 (M1-R399) genes encoding FtsW and FtsW D275A were amplified from pLSM3 and pLSM6 using primers oAT63 and oAT64. After digestion with SacI and XbaI, the PCR products were ligated into pPSV38 to generate pLSM8 and pLSM9, which are overexpression plasmids for PaftsW and PaftsW D275A , respectively. For transformation of P. aeruginosa, plasmids were electroporated into wild-type PAO1, as previously described 34 . Cells were plated on lysogeny broth agar containing gentamycin, and the transformants were recovered after overnight incubation.
S. pneumoniae strain construction. S. pneumoniae R6 and its derivatives were transformed using a previously reported protocol 35 . In brief, cells were grown to mid-log phase and back-diluted to A 600 nm~0 .03 in THY containing 1 mM CaCl 2 , 0.2% bovine serum albumin and other appropriate additives. Competence
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was stimulated by adding 500 pg ml −1 competence-stimulating peptide (CSP-1; AnaSpec) and the cells were incubated for 15 min. To 1 ml culture, 200 ng of DNA product was added and the resulting culture was grown for 1 h. For the selection of transformants, 100 µ l of the culture was combined with 5 ml molten 1% nutrient broth agar supplemented with the appropriate additives, and the mixture was poured over fresh TSAII 5%SB plates. Transformants were recovered after overnight incubation.
Strain AT202 has a zinc-inducible copy of SpftsW inserted in an intergenic region between cpsO and cpsN, as described previously 36 . To construct AT202, the SPD_0952 (M1-K409) gene encoding ftsW was first amplified from D39 ∆ cps genomic DNA using primers oAT65 and oAT66. After digestion with XhoI and BamHI, the PCR product was ligated into pLEM023. The resulting plasmid pATPL139 contains SpftsW under the control of a zinc-inducible P czc promoter with a consensus RBS (P zn -SpftsW) 37 . For integration of this cassette between cpsO and cpsN, the two ~1-kilobase regions flanking this site were amplified from R6 genomic DNA using the primer pairs oAT67/oAT68 and oAT69/oAT70. The P zn -SpftsW cassette and kan gene were amplified from pATPL139 and D39 ∆ bgaA::kan genomic DNA using primer pairs oAT71/oAT72 and oAT73/oAT74, respectively. The four fragments were assembled and amplified by overlap extension PCR. The resulting PCR cassette was transformed into wild-type R6, and the transformants were selected with kanamycin. Integration into the genome was confirmed by diagnostic PCR using primers oAT75 and oAT74.
Strain AT203 was generated by replacing the native ftsW locus of AT202 with an erm cassette. The two ~1-kilobase regions flanking ftsW were amplified from R6 genomic DNA using the primer pairs oAT76/oAT77 and oAT78/oAT79. The two fragments, together with the erm gene amplified from S. pneumoniae D39 ∆ bgaA::erm genomic DNA with primers oAT73 and oAT74, were assembled and amplified by overlapping PCR. The resulting PCR cassette was transformed into AT202, and the transformants were selected with erythromycin and kanamycin on plates supplemented with 0.2 mM ZnSO 4 and 0.02 mM MnCl 2 38 . Integration into the genome was confirmed by diagnostic PCR using primers oAT80 and oAT74.
Strains AT204-AT208 were constructed by inserting a fucose-inducible copy of ftsW in AT203 bgaA locus. SpftsW, SaftsW and StftsW were amplified using primer pairs oAT65/oAT66, oAT81/oAT82 and oAT83/oAT84, respectively. After digestion with XhoI and BamHI, the PCR product was ligated into pAKF205. The resulting plasmids pATPL137, pATPL141 and pATPL142 contain SpftsW, SaftsW and StftsW under the control of a fucose-inducible P fcsk promoter with a consensus RBS (P fucose -ftsW), respectively 39 . Plasmids pATPL138 and pATPL143, containing catalytically inactive SpftsW D289A (SpftsW*) and StftsW D292A (StftsW*) mutants, were PCR generated using primer pairs oAT85/oAT86 and oAT03/oAT04, respectively. Plasmids were transformed into AT203, and the transformants were selected with tetracycline and kanamycin on plates supplemented with 0.2 mM ZnSO 4 and 0.02 mM MnCl 2 . Integration into the genome was confirmed by diagnostic PCR using primers oAT87 and oAT88.
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